A Dramatic Response to Sirolimus Therapy in a Premature Infant With Massive Cardiac Rhabdomyoma

Cardiac rhabdomyomas in neonates may cause significant cardiac risk. Recently, sirolimus has been used to treat these lesions. The dose, duration, and monitoring for therapy are unknown. A case of sirolimus use in a premature neonate is presented. No significant adverse effects were seen. Review of...

Descripción completa

Detalles Bibliográficos
Autores principales: Lawley, Claire, Popat, Himanshu, Wong, Melanie, Badawi, Nadia, Ayer, Julian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289154/
https://www.ncbi.nlm.nih.gov/pubmed/34316818
http://dx.doi.org/10.1016/j.jaccas.2019.07.030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289154/
https://www.ncbi.nlm.nih.gov/pubmed/34316818
http://dx.doi.org/10.1016/j.jaccas.2019.07.030

Ejemplares similares